Join
Live feed
·
INSIDERFilingvia Quantisnow
Nurix Therapeutics Inc. logo

Chief Financial Officer Van Houte Hans converted options into 11,496 shares and sold $60,767 worth of shares (3,661 units at $16.60), increasing direct ownership by 21% to 45,427 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRIX (Nurix Therapeutics Inc.) and more on Quantisnow.